Have a personal or library account? Click to login
Review: conditions causing weak expression of Kell system antigens Cover

Review: conditions causing weak expression of Kell system antigens

By: R. Øyen,  G.R. Halverson and  M.E. Reid  
Paid access
|Nov 2020

References

  1. Coombs RRA, Mourant AE, Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946;i:264–6.10.1016/S0140-6736(46)91925-3
  2. Daniels GL, Anstee DJ, Cartron J-P, et al. Blood group terminology 1995. From the ISBT working party on terminology for red cell surface antigens. Vox Sang 1995;69:265–79.
  3. Marsh WL, Redman CM. The Kell blood group system: a review. Transfusion 1990;30:158–67.10.1046/j.1537-2995.1990.30290162904.x
  4. Lee S, Wu X, Reid ME, Zelinski T, Redman C. Molecular basis of the Kell (K1) phenotype. Blood 1995;85:912–6.10.1182/blood.V85.4.912.bloodjournal854912
  5. Lee S, Wu X, Reid ME, Redman C. Molecular basis of the K:6,–7 [Js(a+b–)] phenotype in the Kell blood group system. Transfusion 1995;35:822–5.10.1046/j.1537-2995.1995.351096026362.x
  6. Lee S, Wu X, Son S, et al. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 1996;36:490–4.10.1046/j.1537-2995.1996.36696269505.x
  7. Advani H, Zamor J, Judd WJ, Johnson CL, Marsh WL. Inactivation of Kell blood group antigens by 2- aminoethylisothiouronium bromide. Br J Haematol 1982;51:107–15.10.1111/j.1365-2141.1982.tb07295.x
  8. Branch DR, Petz LD. Disulphide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity (abstract). Transfusion 1982;22:420.
  9. Allen FH Jr, Lewis SJ, Fudenberg H. Studies of anti- Kpb, a new antibody in the Kell blood group system. Vox Sang 1958;3:1–13.
  10. Tippett P. Expansion of the Lutheran and Kell blood group systems. In: Mohn JF, Plunkett RW, Cunningham RK, Lambert RM, eds. Human blood groups. Basel, Karger, 1977:401–9.
  11. Ford DS, Knight AE, Smith F. A further example of Kpa/Ko exhibiting depression of some Kell group antigens. Vox Sang 1977;32:220–3.
  12. Marsh WL, Jensen L, Øyen R, et al. Anti-K13 and the K:–13 phenotype. A blood-group variant related to the Kell system. Vox Sang 1974;26:34–40.
  13. Kaita H, Lewis M, Chown B, Gard E. A further example of the Kell blood group phenotype K–, k–, Kp(a–b–). Nature 1959;183:1586.10.1038/1831586b0
  14. Nunn HD, Giles DM, Dormandy KM. A second example of anti-Ku in a patient who has the rare Kell phenotype, Ko. Vox Sang 1966;11:611–9.10.1111/j.1423-0410.1966.tb04258.x
  15. Marsh WL, Øyen R, Nichols ME, Allen FH Jr. Chronic granulomatous disease and the Kell blood groups. Br J Haematol 1975;29:247–62.10.1111/j.1365-2141.1975.tb01819.x
  16. Marsh WL, Redman CM. Recent developments in the Kell blood group system. Transfus Med Rev 1987; 1:4–20.10.1016/S0887-7963(87)70002-9
  17. Peloquin P, Yochum G, Hagy L, Øyen R, Johnson C. The Mullins phenotype: another RBC phenotype characterized by weak Kell antigens (abstract). Transfusion 1988;28(Suppl):19S.
  18. Brown A, Berger R, Lasko D, et al. The Day phenotype: a “new” variant in the Kell blood group system. Revue Française de Transfusion et Immuno-hématologie 1982;25:619–27.10.1016/S0338-4535(82)80070-6
  19. Marsh WL, Schnipper EF, Johnson CL, Mueller KA, Schwartz SA. An individual with McLeod syndrome and the Kell blood group antigen K(K1). Transfusion 1983;23:336–8.10.1046/j.1537-2995.1983.23483276871.x
  20. White W, Washington ED, Sabo BH, et al. Anti-Km in a transfused man with McLeod syndrome. Revue Française de Transfusion et Immuno-hématologie 1980;23:305–17.10.1016/S0338-4535(80)80134-6
  21. Øyen R, Reid ME, Rubinstein P, Ralph H. A method to detect McLeod phenotype red blood cells. Immunohematology 1996;12:160–3.10.21307/immunohematology-2019-771
  22. Arndt P, Garratty G, Raghunathan R. Use of flow cytometry for quantitation of mixed RBC populations in female carriers of the McLeod gene (abstract). Transfusion 1994;34(Suppl):21S.
  23. Daniels GL, Weinauer F, Stone C, et al. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells. Blood 1996;88:4045–50.10.1182/blood.V88.10.4045.bloodjournal88104045
  24. Race RR, Sanger R. Blood groups in man. Oxford, England: Blackwell Scientific Publications, 1975.
  25. Reid ME. The Gerbich blood group antigens: a review. Med Lab Sci 1986;43:177–82.
  26. Daniels GL. Studies on Gerbich negative phenotypes and Gerbich antibodies (abstract). Transfusion 1982;22:405.
  27. Anstee DJ, Ridgwell K, Tanner MJ, Daniels GL, Parsons SF. Individuals lacking the Gerbich blood- group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma. Biochem J 1984;221:97–104.10.1042/bj221009711440076466322
  28. Reid ME, Anstee DJ, Tanner MJ, Ridgwell K, Nurse GT. Structural relationships between human erythrocyte sialoglycoproteins beta and gamma and abnormal sialoglycoproteins found in certain rare human erythrocyte variants lacking the Gerbich blood-group antigen(s). Biochem J 1987;244:123–8.10.1042/bj244012311479622444210
  29. Reid ME. Biochemistry and molecular cloning analysis of human red cell sialoglycoproteins that carry Gerbich blood group antigens. In: Unger P, Laird-Fryer B, eds. Blood group systems: MNSsU, Gerbich and glycoproteins. Arlington, VA: American Association of Blood Banks, 1989:73–103.
  30. Anstee DJ. Blood group-active surface molecules of the human red blood cell. Vox Sang 1990;58:1–20.10.1111/j.1423-0410.1990.tb02049.x2180209
  31. Seyfreid H, Górska B, Maj S, Sylwestrowicz T, Giles CM, Goldsmith KLG. Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia. Vox Sang 1972;23:528–36.10.1111/j.1423-0410.1972.tb03846.x4657687
  32. Marsh WL, Øyen R, Alicea E, Linter M, Horton S. Autoimmune hemolytic anemia and the Kell blood groups. Am J Hematol 1979;7:155–62.10.1002/ajh.2830070208539592
  33. Beck ML, Marsh WL, Pierce SR, DiNapoli J, Øyen R, Nichols ME. Auto anti-Kpb associated with weakened antigenicity in the Kell blood group system: a second example. Transfusion 1979;19:197–202.10.1046/j.1537-2995.1979.19279160294.x86215
  34. Williamson LM, Poole J, Redman C, et al. Transient loss of proteins carrying Kell and Lutheran red cell antigens during constructive relapses of autoimmune thrombocytopenia. Br J Haematol 1994;87:805–12.10.1111/j.1365-2141.1994.tb06741.x7527243
  35. Marsh WL, DiNapoli J, Øyen R. Auto-immune hemolytic anemia caused by anti-K13. Vox Sang 1979;36:174–8.10.1111/j.1423-0410.1979.tb04419.x462904
  36. Manny N, Levene C, Sela R, Johnson CL, Mueller KA, Marsh WL. Autoimmunity and the Kell blood groups: auto-anti-Kpb in a Kp(a+b–) patient. Vox Sang 1983;45:252–6.
DOI: https://doi.org/10.21307/immunohematology-2019-711 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 75 - 79
Published on: Nov 9, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 R. Øyen, G.R. Halverson, M.E. Reid, published by American National Red Cross
This work is licensed under the Creative Commons License.